<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>The table lists virus-specific compounds in the order of their relevance, detailing compound class, target and stage of development</p>
 </caption>
 <graphic position="anchor" xlink:href="11262_2020_1737_Tab1a_HTML" id="MO11" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <graphic position="anchor" xlink:href="11262_2020_1737_Tab1b_HTML" id="MO21" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <graphic position="anchor" xlink:href="11262_2020_1737_Tab1c_HTML" id="MO31" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <graphic position="anchor" xlink:href="11262_2020_1737_Tab1d_HTML" id="MO41" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <table-wrap-foot>
  <p>Lead small-molecule drug candidates are highlighted in yellow</p>
  <p>
   <italic>Appr.</italic> approved, 
   <italic>FDA</italic> US Food and Drug Administration, 
   <italic>IND</italic> FDA investigational drug, 
   <italic>NHP</italic> non-human primates, 
   <italic>NSAID</italic> non-steroidal anti-inflammatory drug, 
   <italic>Phase</italic> clinical trial phase I to III, 
   <italic>Pol</italic> viral polymerase, 
   <italic>Prot</italic> viral protease, 
   <italic>Vs</italic>. versus, + more viruses, not listed
  </p>
 </table-wrap-foot>
</table-wrap>
